-
Solving the PICO Puzzle: Perspectives on Outcome Measures for Oncology Medicines in Assessments of the European Medicines Agency and Health Technology Assessment Organizations in Europe
Sep 9, 2025, 16:22 PM -
Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Prostate Cancer Management Using Electronic Health Record-Derived Data From the UK
Sep 9, 2025, 16:22 PM -
Caregiver QALYs Deserve Better: Why It's Time for a Methodological Rethink
Sep 9, 2025, 16:22 PM -
Application of Network Meta-Analysis in Vaccine Research: An Illustration Using Immunogenicity of Pneumococcal Vaccines in Adults
Sep 9, 2025, 16:22 PM -
Bayesian Parametric Mixture Cure Survival Models With Delayed Treatment Effects and Application to Targeted Therapies in Advanced Ovarian Cancer
Sep 9, 2025, 16:22 PM -
Granulocyte-Colony Stimulating Factor (G-CSF) Reference and Biosimilar Products Using Real-World Data to Assess Data Variability Across Different Sources to Evaluate its Potential Utility in Regulatory Assessment: A Study by the Biologics and...
Sep 9, 2025, 16:22 PM -
Knowledge of Natural Contraception and Its Effect on the Relationship: Mobile Application
Sep 9, 2025, 16:22 PM -
Improving the Conceptual Coverage of the 15-item Penn Parkinson’s Daily Activity Questionnaire (PDAQ-15) for Use in the Mild-to-Moderate Lewy Body Dementia Population
Sep 9, 2025, 16:22 PM -
The Development of the Private Healthcare Sector in Romania Between 2005 and 2023
Sep 9, 2025, 16:22 PM -
The Landscape of the Use of Artificial Intelligence and Machine Learning (AIMI) Methods in Health Technology Assessment (HTA) Submissions
Sep 9, 2025, 16:22 PM -
Health Halo Effect in Supplement Marketing: A Content Analysis of Medical Claims in Community Pharmacies
Sep 9, 2025, 16:22 PM -
Data Linkage to Support Real-World Evdence in Rare Disease
Sep 9, 2025, 16:22 PM -
AI-Assisted Time-to-Event Projection: A Case Study and Broader Potential
Sep 9, 2025, 16:22 PM -
Defining Unavoidable Uncertainty in HTA: Towards More Flexible and Adapted Approaches for Promising Treatments
Sep 9, 2025, 16:22 PM -
Organizational Readiness for EU HTA: Early Learnings and Key Considerations for Successful Market Access
Sep 9, 2025, 16:22 PM -
Towards Shaping Rare Diseases and Orphan Drugs Health Ecosystem in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Lebrikizumab vs. Alternative Biologics in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis in the UK
Sep 9, 2025, 16:22 PM -
Enhancing Operational Efficiency: Time and Cost Savings of a Minimally Invasive Vascular Closure Device in Germany
Sep 9, 2025, 16:22 PM -
Comparative Evaluation of Sequence-Encoding Strategies for Clustering Inhaled Therapy Pathways in COPD Patients Using Real-World Data
Sep 9, 2025, 16:22 PM
